The formation of complexes between growth factor receptors and members of a family of G-proteincoupled receptors whose natural ligands are S1P (sphingosine 1-phosphate) and LPA (lysophosphatidic acid) represents a new signalling entity. This receptor complex allows for integrated signalling in response to growth factor and/or S1P/LPA and provides a mechanism for more efficient activation (due to integrated close-proximity signalling from both receptor classes) of the p42/p44 MAPK (mitogen-activated protein kinase) pathway. This article provides information on the molecular events at the interface between receptor tyrosine kinases and S1P/LPA receptors. Examples include the PDGF (platelet-derived growth factor)-induced tyrosine phosphorylation of G i α, released upon S1P 1 receptor activation, which is required for initiation of the p42/p44 MAPK pathway. Critical to this event is the formation of endocytic vesicles containing functionally active PDGFβ receptor-S1P 1 receptor complexes, which are internalized and relocated with components of the p42/p44 MAPK pathway. We also report examples of cross-talk signal integration between the Trk A (tropomyosin receptor kinase A) receptor and the LPA 1 receptor in terms of the NGF (nerve growth factor)-dependent regulation of the p42/p44 MAPK pathway. NGF induces recruitment of the LPA 1 receptor to the nucleus (delivery might be Trk A-dependent), whereupon the LPA 1 receptor may govern gene expression via novel nuclear signalling processes.
Introduction
Mitogenic stimuli initiate cell proliferation via different classes of cell-surface receptor, which include growth factor receptor tyrosine kinase receptors and GPCRs (G-proteincoupled receptors). This involves and requires stimulation of the p42/p44 MAPK (mitogen-activated protein kinase) pathway. In this regard, it is known that certain GPCR agonists can function as co-mitogens with growth factors to stimulate DNA synthesis. Both growth factors and GPCR agonists stimulate the tyrosine phosphorylation of Shc and the sequential activation of Grb-2-mSos, Ras, c-Raf, MEK1 (MAPK/extracellular-signal-regulated kinase kinase 1) and p42/p44 MAPK [1] .
Recent studies have provided more information on the molecular basis of co-mitogenicity. These studies have demonstrated that certain growth factors can use classic GPCRmediated signalling pathways to stimulate p42/p44 MAPK in mammalian cells. For instance, the IGF-1 (insulin-like growth factor-1) receptor utilizes the G-protein G i to stimulate activation of p42/p44 MAPK in fibroblasts. This was established using pertussis toxin (which uncouples GPCRs from G i/o ) and the C-terminal domain of β-adrenergic kinase [also known as GRK2 (G-protein-coupled receptor kinase 2), Abbreviations used: ASM, airway smooth muscle; GPCR, G-protein-coupled receptor; GRK2, G-protein-coupled receptor kinase 2; IGF-1, insulin-like growth factor-1; LPA, lysophosphatidic acid; MAPK, mitogen-activated protein kinase; NGF, nerve growth factor; PDGF, platelet-derived growth factor; PKC, protein kinase C; S1P, sphingosine 1-phosphate; SphK, sphingosine kinase; Trk, tropomyosin receptor kinase; MEK1, MAPK/extracellular-signal-regulated kinase kinase 1. 1 To whom correspondence should be addressed (e-mail n.j.pyne@strath.ac.uk).
which sequesters Gβγ subunits], both of which reduced the IGF-1-dependent activation of p42/p44 MAPK [2] . Hallak et al. [3] also demonstrated that the IGF-1 receptor forms a complex with G i αβγ and that IGF-1 stimulates release of the G-protein βγ subunits, which initiates activation of the p42/p44 MAPK pathway.
S1P 1 receptor and PDGFβ (platelet-derived growth factor β) receptor signalling interaction in HEK-293 cells
To date, five closely related GPCRs of the EDG (endothelial differentiation gene) family (S1P 1 -S1P 5 ) have been identified as high-affinity S1P (sphingosine 1-phosphate) receptors (see [4] for review). The S1P 1 receptor is implicated in regulating smooth muscle cell migration, proliferation and vascular maturation. Interestingly, disruption of the s1p 1 gene by homologous recombination in mice results in extensive intraembryonic haemorrhaging and intra-uterine death [5] . This is caused by incomplete vascular maturation due to the failure of mural cells, vascular smooth muscle cells and pericytes to migrate to arteries and capillaries and to reinforce them properly. Moreover, the disruption of the pdgf β receptor gene in mice results in a similar phenotype [6] . These findings suggest that there may be cross-talk between the S1P 1 and the PDGFβ receptor signalling systems. This possibility was supported by results showing that PDGF-stimulated cell motility is S1P-dependent in HEK-293 cells and mouse embryonic fibroblasts [7] . Hobson et al. [7] reported that PDGF stimulated the release of S1P from SphK1 (sphingosine kinase 1)-transfected HEK-293 cells and that the released Scheme 1 PDGFβR (PDGFβ receptor)-S1P 1 receptor complex signalling PDGF stimulates tyrosine phosphorylation of G i α (released upon activation of S1P 1 receptors by S1P) required for the activation of the p42/p44 MAPK pathway and promoted by proximity-induced effects by association of the PDGFβ receptor with S1P 1 receptor. GRK2/β-arrestin I is recruited to the PDGFβ receptor via its association with the S1P 1 receptor. This may involve the Gβγ-dependent recruitment of GRK2/β-arrestin I to the receptor complex and association with clathrin adaptors for subsequent endocytic filling with active receptor signal complexes (including Raf, c-Src etc.). The PDGF receptor also stimulates the G i -dependent tyrosine phosphorylation of Gab1 (Grb-2-associated binder 1), which promotes recruitment of dynamin to a PI3K (phosphoinositide 3-kinase)-Gab1 complex. Once associated with this complex, dynamin II may catalyse the pinching off of the endocytic vesicle containing the PDGFβ receptor-S1P 1 receptor signalling complex for re-localization with and activation of cytoplasmic MEK1 and p42/p44 MAPK. S1P binds to the S1P 1 receptor to induce the activation of Rac (low-molecular-mass G-protein), which is required for regulation of cell motility. This is therefore a sequential or autocrine mechanism of action of PDGF/S1P signalling.
In contrast, we have reported that the PDGFβ receptor forms a complex with the S1P 1 receptor in transfected HEK-293 cells [8] . The PDGFβ receptor can be co-immunoprecipitated with Myc-tagged S1P 1 receptor using either anti-(PDGFβ receptor) or anti-Myc-tag antibodies, suggesting a close interaction between these receptors. The PDGFβ receptor-S1P 1 receptor complex represents a novel platform upon which GPCR-and receptor tyrosine kinase-dependent signals are integrated to produce more efficient PDGF and S1P stimulation of the p42/p44 MAPK pathway in HEK-293 cells. This occurs through a mechanism that involves the PDGFβ receptor kinase-catalysed tyrosine phosphorylation of G i α released upon stimulation of the S1P 1 receptor (Scheme 1). Indeed, pre-treatment of cells with pertussis toxin almost completely abolished PDGF-and S1P-stimulated activation of p42/p44 MAPK in these cells. We also showed that the association of the receptor types allows more efficient tyrosine phosphorylation of G i α via proximity-induced effects that is required for PDGF and S1P to stimulate the p42/p44 MAPK pathway (Scheme 1).
This model of integrative signalling predicts that PDGF stimulation of cell responses may be dependent upon the S1P 1 receptor, while S1P stimulation requires the PDGFβ receptor. This is indeed the case. Thus over-expression of the S1P 1 receptor (which is partially constitutively activated) in HEK-293 cells increased the PDGF-dependent activation of p42/p44 MAPK, while over-expression of the PDGFβ receptor (which exhibits high basal tyrosine kinase activity) enhanced S1P stimulation of this kinase pathway via both endogenous S1P receptors and recombinant S1P 1 receptors [8] . The latter is particularly significant because the potentiation of S1P signalling by over-expression of PDGFβ receptors is independent of released endogenous S1P. In addition, exogenous S1P does not stimulate the release of PDGF, nor does it induce PDGFβ receptor tyrosine phosphorylation, while SphK inhibitors, such as DL-threo-dihydrosphingosine or N,N-dimethylsphingosine, fail to inhibit the PDGFstimulated activation of p42/p44 MAPK in HEK-293 cells [8] . These data exclude a sequential/autocrine function of S1P. Overall, the data are therefore compatible with the integrative signalling model in terms of p42/p44 MAPK activation that might form the molecular basis for co-mitogenicity between growth factors and GPCR agonists.
GRK2 and β-arrestin I are implicated in the regulation of IGF-1-stimulated endocytic signalling and activation of the p42/p44 MAPK pathway. GRK2 is activated in an agonistand Gβγ subunit-dependent manner. β-Arrestin is a clathrin adaptor protein that is recruited to ligand-bound GPCRs that have been phosphorylated by GRK2 and promotes dynamin-mediated endocytosis of receptor signal complexes containing Raf-1-MEK1 for subsequent activation of p42/p44 MAPK. Thus β-arrestin I appears to play a critical role in receptor-mediated endocytic signalling. Recent studies by Dalle et al. [9] have also shown that IGF-1 promotes the binding of β-arrestin I to the IGF-1 receptor in adipocytes, while we have demonstrated that NGF (nerve growth factor) stimulates β-arrestin I binding to a GRK2-Trk A (tropomyosin receptor kinase A) receptor complex in PC12 cells [10] . β-Arrestin I/GRK2 are also associated with the PDGFβ receptor-S1P 1 receptor complex in HEK-293 cells, suggesting that PDGFβ receptor endocytic signalling may be initiated by GRK2/β-arrestin I that has been recruited to the PDGFβ receptor by association of the latter with the S1P 1 receptor [8] (Scheme 1). Therefore, we suggest that PDGFβ receptor-S1P 1 receptor signalling might involve both G i α-and Gβγ-mediated pathways (Scheme 1). Indeed, sequestration of Gβγ subunits with C-terminal GRK2 peptide and dominant-negative β-arrestin I mutant block PDGF-and S1P-stimulated p42/p44 MAPK activation in transfected HEK-293 cells (C. Waters and N.J. Pyne, unpublished work).
S1P/PDGF signalling in cultured ASM (airway smooth muscle) cells
ASM cells represent a useful model for investigating the mechanisms of co-mitogenic signalling, since pertussis toxin reduces PDGF-stimulated activation of c-Src/p42/p44 MAPK (c-Src is implicated in the regulation of the p42/ p44 MAPK pathway in these cells) by 50 %, thereby suggesting a role for a GPCR-mediated pathway [11] . In the first instance, several new lines of evidence were obtained to support the existence of a functionally active native PDGFβ receptor-S1P 1 receptor complex in ASM cells [12] . First, the PDGFβ and S1P 1 receptors were co-immuno-precipitated from cell lysates with specific anti-S1P 1 /-PDGFβ receptor antibodies. Second, the treatment of ASM cells with PDGF or S1P stimulated the phosphorylation of p42/p44 MAPK and this phosphorylated p42/p44 MAPK associated with the PDGFβ receptor-S1P 1 receptor complex. The close association of phosphorylated p42/p44 MAPK with the PDGFβ receptor-S1P 1 receptor complex is entirely compatible with an integrative signalling response to PDGF and S1P. Thirdly, the treatment of cells with an antisense S1P 1 receptor plasmid construct (which lowered S1P 1 receptor expression) reduced the PDGF-and S1P-dependent activation of p42/p44 MAPK. These findings suggest that the S1P 1 receptor might be partially constitutively active and capable of releasing active G-protein subunits for utilization by the PDGFβ receptor. Fourthly, S1P and/or PDGF promoted the co-internalization of PDGFβ receptor and S1P 1 receptor in the same endocytic vesicles. This was also evident in transfected HEK-293 cells. We excluded a sequential model in which PDGF stimulates release of S1P based on data showing that inhibitors of SphK or wild-type or dominant-negative SphK1 did not modulate PDGF-stimulated activation of p42/p44 MAPK, protein kinase B or p38 MAPK [12] .
A fraction of the PDGF-stimulated activation of p42/p44 MAPK in ASM cells is insensitive to pertussis toxin. Thus part of the response does not involve G i or S1P 1 receptors. This is an interesting finding and is supported by other evidence, which suggests that the G-protein input into signalling by receptor tyrosine kinases is dependent upon both receptor density and ligand concentration. Thus high receptor tyrosine kinase density or ligand concentration has been shown to surmount the requirement for G-protein input. These findings suggest that the PDGFβ receptor might utilize at least two distinct signalling pathways to stimulate p42/p44 MAPK. We have proposed that one pathway requires G-protein, while the other is probably initiated by tyrosine autophosphorylation of the growth factor receptor. Indeed, the G-protein-dependent activation of p42/p44 MAPK in response to PDGF occurs via a mechanism that does not require PDGF-dependent tyrosine phosphorylation of the PDGFβ receptor. Furthermore, over-expression of G i suppresses PDGFβ receptor tyrosine phosphorylation, while increasing PDGF-stimulated activation of p42/p44 MAPK in HEK-293 cells [8] . These findings have been confirmed by Freedman et al. [13] , who demonstrated that the GRK2-catalysed phosphorylation of the PDGFβ receptor suppresses its PDGF-stimulated tyrosine autophosphorylation. We have therefore suggested that G-protein input may switch growth factor receptor signalling, such that stimulation of p42/p44 MAPK is less dependent upon recruitment of proteins to tyrosine phosphates on the growth factor receptor, and is more dependent upon a G i /GRK2/β-arrestin I-mediated pathway (Scheme 1).
Thus endocytosis of the PDGFβ receptor signal complexes (including c-Src) appears to be promoted, in part, by a G i PCR-dependent mechanism and is required for activation of p42/p44 MAPK. Thus increased internalization of PDGFβ receptor-S1P 1 receptor complex in response to combined stimulation with S1P and PDGF will improve the efficiency with which PDGF (and vice versa, with S1P) stimulates the p42/p44 MAPK pathway. This might represent the molecular basis for co-mitogenic interaction between S1P and PDGF, which is manifested in increased DNA synthesis in ASM cells. In addition, we have shown that the PDGF receptor utilizes a G-protein-dependent Gab1 (Grb-2-associated binder 1)/phosphoinositide 3-kinase/dynamin II pathway to regulate endocytic signalling by the PDGFβ receptor (Scheme 1) [14] . This mechanism of endocytic signalling is distinct from that observed when growth factor receptors are transactivated by GPCR agonists. In this regard, Maudsley et al. [15] showed that isoprenaline induces transactivation of the epidermal growth factor receptor resulting in receptor tyrosine phosphorylation and complex formation with β-adrenergic receptors. Under these conditions, isoprenaline induces the co-internalization of β-adrenergic receptors and epidermal growth factor receptors to the same endocytic vesicles. However, epidermal growth factor alone does not induce internalization of the β-adrenergic receptor. This contrasts with our findings, where we show that PDGF induces co-internalization of both PDGFβ and S1P 1 receptors [12] . We conclude that integrative signalling and co-internalization of both PDGFβ receptors and S1P 1 receptors in response to PDGF and/or S1P is a novel important mitogenic mechanism, distinct from transactivation.
NGF signalling in PC12 cells
NGF is a member of the neurotrophin family [16] . It functions as a survival factor against cell death or cell cytostasis and promotes neuronal cell differentiation. Thus survival rates of PC12 cells in the absence of serum are increased in the presence of NGF [17] . The bioactive lysolipid, LPA (lysophosphatidic acid), has been identified in serum and can markedly promote the differentiation and survival of myelinating cells without stimulating DNA synthesis. When differentiated PC12 cells are challenged with LPA, they undergo acute growth cone collapse and neurite retraction, often followed by their degeneration, accompanied by transient rounding of the cell body [18, 19] .
NGF binds to the tyrosine kinase receptor termed Trk A to regulate p42/p44 MAPK via a Ras/c-Raf pathway.
Binding of NGF to the Trk A receptor promotes binding of FRS2 to the receptor. FRS2 (fibroblast growth factor receptor substrate) is required for persistent activation of Rap1 and consequently B-Raf, which is required to regulate the p42/p44 MAPK pathway in neuronal cells [20] . The NGF-dependent activation of p42/p44 MAPK is reduced by pre-treating PC12 cells with pertussis toxin [10] . Since pertussis toxin acts to uncouple GPCRs from their respective G-proteins, these results suggest that the Trk A receptor might also use classic GPCR-mediated signalling pathways to stimulate p42/p44 MAPK in these cells. In this regard, we reported that GRK2 is constitutively associated with the Trk A receptor and that NGF promotes binding of β-arrestin I to the GRK2-Trk A receptor complex in a pertussis toxin-sensitive manner [10] . Furthermore, overexpression of recombinant GRK2 or β-arrestin I increased the NGF-dependent activation of p42/p44 MAPK in PC12 cells [10] .
Several new lines of evidence are presented here which support a model in which the LPA 1 receptor signalling system interacts with the Trk A receptor and functions to promote more efficient activation of p42/p44 MAPK. This is achieved by employing both receptor tyrosine kinase and GPCR signalling components in an integrative manner (Scheme 2). Thus co-stimulation with sub-maximal NGF/LPA produced a synergistic activation of p42/p44 MAPK. The transfection of an LPA 1 receptor antisense construct reduced LPA-and NGF-dependent activation of p42/p44 MAPK, while the responses were potentiated by over-expression of the recombinant wild-type LPA 1 receptor. These data are consistent with a model in which Trk A receptor signalling is LPA 1 -dependent. A major finding is that NGF and/or LPA promote recruitment of the LPA 1 receptor to the nucleus. Interestingly, the LPA 1 receptor contains a potential nuclear targeting motif (PRRNRD). This is absent from all other LPA/S1P receptors belonging to the EDG (endothelial differentiation gene) cluster and the Trk A receptor. This targeting motif might confer ability on the LPA 1 receptor to translocate to the nucleus in response to NGF and/or LPA. Importantly, the Trk A receptor may act as a chaperone for nuclear targeting of the LPA 1 receptor. This might be a consequence of close interaction between the LPA 1 receptor and Trk A receptor and utilization of tyrosine kinase-dependent components required for endocytosis. In this regard, both NGF and/or LPA promote localization of the Trk A receptor to a perinuclear region, which itself may use G-protein components regulating clathrinmediated endocytosis. Thus, the Trk A receptor might effectively participate in delivering the LPA 1 receptor to the nucleus, whereupon a pool of Trk A receptor remains in endocytic vesicles close to a perinuclear region. Indeed, this pool of Trk A receptor may play an important role in the regulation of p42/p44 MAPK, which is known to interact, possibly temporally, with β-arrestin I. As stated above, LPA and NGF stimulate concerted activation of the p42/p44 MAPK pathway. Thus LPA might provide G-protein that can be used by the Trk A receptor to stimulate Scheme 2 Trk A receptor-LPA 1 receptor complex signalling LPA and NGF stimulate concerted activation of the p42/p44 MAPK pathway. Thus LPA might provide G-protein that can be used by the Trk A receptor to stimulate the p42/p44 MAPK pathway. Activated p42/p44 MAPK translocates to the nucleus to regulate subsets of genes via activation of AP-1 (activator protein-1) required for differentiation. The Trk A receptor might deliver LPA 1 receptor to the nucleus in response to LPA/NGF, whereupon a pool of Trk A receptor remains in endocytic vesicles close to a perinuclear region. Nuclear-localized LPA 1 receptor might induce additional subsets of genes required for differentiation via novel nuclear signalling pathways.
the p42/p44 MAPK pathway. Activated p42/p44 MAPK translocates to the nucleus (termed here indirect nuclear signalling) to regulate additional subsets of genes via activation of AP-1 (activator protein-1), possibly distinct from those activated by NGF-dependent nuclear-localized LPA 1 receptors (termed here direct nuclear signalling), both of which may be required for differentiation.
We conclude that sub-maximal NGF might re-programme LPA to act predominantly via the nuclear-targeted LPA 1 receptor/p42/p44 MAPK signalling system thereby converting LPA from being pro-apoptotic to a co-differentiating stimulus.
Conclusion
We propose that different genetic programmes are activated when growth factor receptors and GPCRs are in a complex compared with when these receptors are expressed separately in cells. Therefore, future objectives are to identify gene clusters that are specifically induced when PDGFβ receptor-S1P 1 receptor and Trk A-LPA 1 receptor complexes are activated by ligands. The focus will be on genes whose products affect mitogenesis/differentiation (e.g. early genes, such as c-fos) and genes whose products affect S1P/LPA metabolism and action. It is anticipated that these studies will define (i) the molecular basis for the formation of receptor tyrosine kinase and GPCR signalling complexes in terms of mitogenic and differentiation signalling and (ii) the genes whose action requires complex formation between receptor tyrosine kinases and GPCRs. The latter are important in terms of regulation of key cellular processes in both health and disease (hyperproliferative and degenerative).
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